Prenatal lipopolysaccharide exposure programs the early-life lung development by modulating mesenchymal fibroblasts in a time- and dose-dependent manner

BACKGROUND: Bronchopulmonary dysplasia (BPD) is one common and severe complication of preterm births. Prenatal infection/inflammation is the major cause driving preterm deliveries, but its contribution to the early-life lung development remains unclear. METHODS: Pregnant C57BL/6J mice were randomized at 15.5 or 18.5 days post coitum (dpc) to receive intraperitoneal injection of sterile saline, lipopolysaccharide (LPS) 50

  • Dong, Y.
  • Hadzic, S.
  • Leidner, A.
  • Marega, M.
  • Procida-Kowalski, T.
  • Bartkuhn, M.
  • Rivetti, S.
  • Ehrhardt, H.
  • Bellusci, S.

Keywords

  • Bronchopulmonary dysplasia
  • Lps
  • Lipofibroblast
  • Myofibroblast
  • Prenatal inflammation
Publication details
DOI: 10.1186/s12916-025-04533-w
Journal: BMC Med
Work Type: Original
Access number: 41430213
More information
chevron-down